Zimmer Biomet reports Q1 adjusted EPS $1.94, consensus $1.87

Reports Q1 revenue $1.89B, consensus $1.87B. “We are very pleased with the execution, progress and strong performance the team delivered in the first quarter,” said Ivan Tornos, Zimmer Biomet’s President and Chief Executive Officer. “As we move forward, we are focused on continuing this momentum and delivering on our key priorities to advance people and culture, achieve operational excellence and drive innovation and diversification – all with the goal of delivering on our Mission.”